News | August 15, 2022
Arbitrator rules in favor of Daiichi Sankyo in dispute with Seagen
All claims made by Seagen regarding Daiichi Sankyo antibody drug conjugates are denied
All claims made by Seagen regarding Daiichi Sankyo antibody drug conjugates are denied
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
In the first phase of the Grangemouth site expansion, two new ADC manufacturing suites, operational by Q3 2023, will be added to the existing three
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
Subscribe To Our Newsletter & Stay Updated
